InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Klein Christopher, Conseiller Général. Insider active across 3 companies, notably Osmotica Pharmaceuticals plc. Aggregated, 7 disclosures have been published. History available since 18 May 2021. The latest transaction was filed on 18 May 2023 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Declarations7 total
5,447 shares@ US$0.8710.3% of flowOrdinary SharesSEC:0001104659-23-063321:0
9,608 shares@ US$1.2626.0% of flowOrdinary SharesSEC:0001104659-23-007069:0
6,127 shares@ US$1.4030.0% of flowOrdinary SharesSEC:0001104659-22-063392:0
9,607 shares@ US$1.1335.0% of flowOrdinary SharesSEC:0001104659-22-007843:0
9,607 shares@ US$1.13100.0% of flowOrdinary SharesSEC:0001104659-22-007843
6,467 shares@ US$3.12100.0% of flowOrdinary SharesSEC:0001104659-21-069881
6,467 shares@ US$3.12100.0% of flowOrdinary SharesSEC:0001104659-21-069881:0
7 of 7 declarations
About Klein Christopher
Christopher Klein is the General Counsel and Secretary at Osmotica Pharmaceuticals plc and RVL Pharmaceuticals plc. In this role, he oversees the legal and regulatory affairs of the companies. His expertise in pharmaceutical law is essential for ensuring compliance and managing legal risks.
